Milestone Scientific
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Milestone Scientific generated cash of -$5,326,129, which is more than the previous year. Cash used in financing activities reached the amount of $2,560,735 last year. Net change in cash is therefore -$5,737,566.
Cash Flow
| 2014 | 376.94K | -1.30M | 10.14M |
|---|---|---|---|
| 2015 | -2.94M | -3.72M | 500K |
| 2016 | -5.39M | 8.20K | 4.79M |
| 2017 | -1.22M | -199.17K | 463.33K |
| 2018 | -1.62M | -15.42K | -250K |
| 2019 | -1.77M | -9.91K | 2.56M |
| 2020 | -6.98M | -21.43K | 19.71M |
| 2021 | -4.01M | -15.18K | 4.57M |
| 2022 | -6.03M | -8.52K | -8.54K |
| 2023 | -5.32M | -2.97M | 2.56M |
MLSS Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 8.71M | 14.76M | 14.22M | 1.51M | 743.42K | 2.63M | 3.60M | 4.19M | 10.36M | 1.14M |
Operating activities | ||||||||||
Net income | -6.92M | -8.77M | -6.87M | -7.38M | -7.58M | -7.69M | -5.36M | -7.29M | -5.53M | -1.70M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 150.36K | 144.37K | 73.83K | 95.94K | 256.47K | 881.28K | 573.15K | 163.36K | 97.37K | 95.83K |
Stock-based compensation expense | 1.88M | 1.81M | 1.58M | 1.34M | 183.88K | 0 | 651.41K | 1.85M | 1.12M | 1.03M |
| Deferred income tax benefit | 1.88M | 1.81M | 1.58M | 1.34M | 183.88K | 0 | 651.41K | 1.85M | 1.12M | 1.03M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 309.94K | 249.55K | 137.38K | 630.00K | 367.79K | -635.48K | 256.02K | -1.09M | -207.24K | -8.62K |
Inventories | -1.10M | -833.12K | 878.66K | -799.67K | 300.54K | 914.61K | 1.00M | -509.46K | -875.03K | -1.17M |
Accounts payable | -806.10K | 729.93K | 308.17K | -1.87M | 16.89K | 905.94K | -612.95K | 486.34K | 173.06K | -516.46K |
Cash generated by operating activities | -5.32M | -6.03M | -4.01M | -6.98M | -1.77M | -1.62M | -1.22M | -5.39M | -2.94M | 376.94K |
Investing activities | ||||||||||
Purchases Of Investments | -7.93M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.64M | -1.20M |
Investments In Property Plant And Equipment | -4.88K | -8.52K | -15.18K | -21.43K | -9.91K | -7.40K | -199.17K | -30.95K | -77.52K | -98.96K |
Acquisitions Net | 2.96M | 0 | 0 | 0 | 0 | -8.02K | 0 | 39.16K | -3.64M | -1.20M |
Cash generated by investing activities | -2.97M | -8.52K | -15.18K | -21.43K | -9.91K | -15.42K | -199.17K | 8.20K | -3.72M | -1.30M |
Financing activities | ||||||||||
Common Stock Issued | 2.57M | 0 | 4.59M | 19.44M | 2.22M | 0 | 400.83K | 4.79M | 0 | 9.44M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | -250K | 0 | 0 | 0 | 0 |
Repayments of term debt | -9.36K | -8.54K | -24.73K | -7.62K | 0 | 0 | 0 | 0 | 0 | -50K |
Cash used in financing activities | 2.56M | -8.54K | 4.57M | 19.71M | 2.56M | -250K | 463.33K | 4.79M | 500K | 10.14M |
Net Change In Cash | -5.73M | -6.04M | 540.42K | 12.70M | 772.84K | -1.89M | -965.27K | -592.15K | -6.17M | 9.22M |
Cash at end of period | 2.97M | 8.71M | 14.76M | 14.22M | 1.51M | 743.42K | 2.63M | 3.60M | 4.19M | 10.36M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |